Trial intelligence / Profile preview

Calcipotriol for Prevention of Polymorphic Light Eruption

2008-000626-39Phase 2Completed

Sponsor
Medical University of Graz
Start
Jul 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of calcipotriol in polymorphic light eruption (PMLE), sponsored by Medical University of Graz. Primary endpoint: PLD Score. Started Jul 2008; status: completed.

02

Drugs

calcipotriol
03

Conditions

polymorphic light eruption (PMLE)

Beyond the preview

Go deeper on 2008-000626-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-000626-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call